GENDER DIFFERENCES OF CLINICAL MANIFESTATION AND CARDIAC REMODELING IN IDIOPATHIC HYPERTROPHIC CARDIOMYOPATHY IN ELDERLY PATIENTS

Aim. To study gender differences of clinical course and myocardial remodeling in elderly patients with idiopathic hypertrophic cardiomyopathy (HCM).

Material and methods. The study included 131 patients with idiopathic HCM. Patients underwent standard clinical, laboratory and instrumental diagnostics.

Results. In the elderly patients with idiopathic HCM, proportion of females was 63% (n=82), males — 37% (n=49). Mean age of females 69±7 y. o., males — 68±7 y. o. Coronary artery disease (CAD) was more common in males (32%) than in females (22%), but with no significant difference (p=0,2). Atrial fibrillation was more common in males (49% vs 29%, respectively, p=0,03). Size of the left atrium and enddiastolic size of the left ventricle in males exceeded those in females (51,2±9,0 mm versus 46,3±4,7 mm, 51,5±7,6 mm versus 45,6±5,7 mm, respectively, p=0,01). In males, symmetrical myocardial remodeling was found more often (42% vs 25%, p=0,04). Obstructive form of HCM was predominant in females (45% and 14%, p=0,01). Chronic heart failure (CHF) with NYHA class III was found in 29% in female group (n=24) and in 12% in male group (n=6), with a tendency to difference (p=0,06). In females, CHF with NYHA class III was mostly due to the left ventricle outflow tract obstruction (n=13) and dilatation phase (n=3). In males, almost all cases of CHF in NYHA class III-IV (8 of 9 patients) were a result of combination of HCM with CAD and previous myocardial infarction. In males, the ejection fraction was significantly lower (55,7±14,8% versus 62,2±10,9%, p=0,01).

Conclusion. Proportion of females was higher in elderly patients with idiopathic HCM. Females with HCM were characterized by a more severe course of the disease due to the left ventricle outflow tract obstruction and dilatation phase. In males with idiopathic HCM there were registered more often the following: atrial fibrillation, larger left atrium and end-diastolic size of the left ventricle, symmetrical myocardial remodeling, lower ejection fraction of the left ventricle, — probably associated with a combination of HCM with CAD and previous myocardial infarction.

1. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. European Heart Journal 2014; 35: 273379. DOI: 10.1016/j.rec.2014.10.011.

2. Olivotto I, Maron MS, Adabag AS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46: 480-7. DOI: 10.1016/j.jacc.2005.04.043.

3. Dimitrow PP, Czarnecka D, Jaszcz KK, et al. Sex differences in age at onset of symptoms in patients with hypertrophic cardiomyopathy. J Cardiovasc Risk 1997; 4: 33-5.

4. Lin CL, Chiang CW, Shaw CK, et al. Gender differences in the presentation of adult obstructive hypertrophic cardiomyopathy with resting gradient: a study of 122 patients. Jpn Circ J 1999; 63: 859-64.

5. Kubo T, Kitaoka H, Okawa M, et al. Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study. J Cardiol 2010; 56: 314-9. DOI: 10.1016/j.jjcc.2010.07.004.

6. Arad M, Seidman JG, Seidman CE. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 2002; 11: 2499-506.

7. Olivotto I, Girolami F, Nistri S, et al. The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice. J Cardiovasc Transl Res 2009; 2: 349-67. DOI: 10.1007/s12265-009-9137-2.

8. Terauchi Y, Kubo T, Baba Y, et al. Gender differences in the clinical features of hypertrophic cardiomyopathycaused by cardiac myosin-binding protein C gene mutations. J Cardiol 2015; 65 (5): 423-8. DOI: 10.1016/j.jjcc.2014.07.010.

9. Brugada R, Kelsey W, Lechin M, et al. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Investig Med 1997; 45: 542-51.

10. Russell JW, Biller J, Hajduczok ZD, et al. Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis. Stroke 1991; 22: 1143-7.

11. Geske JB, Ong KC, Siontis KC, et al. Women with hypertrophic cardiomyopathy have worse survival. Eur Heart J 2017; 38 (46): 3434-40. DOI: 10.1093/eurheartj/ehx527.

12. Zegkos T, Efthimiadis GK, Parcharidou DG, et al. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality. Hellenic J Cardiol 2017; 58: 331-9. DOI: 10.1016/j.hjc.2017.01.027.

13. Guttmann OP, Pavlou M, O’Mahony C, et al. Predictors of atrial fibrillation in hypertrophic cardiomyopathy. Heart 2017; 103 (9): 672-8. DOI: 10.1136/heartjnl-2016-309672.

14. Dimitrow PP, Czarnecka D, Strojny JA, et al. Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol 2001; 77: 43-8.